Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial,”1 published online July 30, 2020, an error appeared in the text. In the Methods section, the age of eligible participants should have been 50 years or older not 50 years or younger. The article has been corrected online.
Error in Text. JAMA Ophthalmol. 2020;138(9):1006. doi:10.1001/jamaophthalmol.2020.3537
Create a personal account or sign in to: